4//SEC Filing
GLADNEY DAN W 4
Accession 0001371217-18-000002
CIK 0001371217other
Filed
Apr 19, 8:00 PM ET
Accepted
Apr 20, 4:54 PM ET
Size
6.0 KB
Accession
0001371217-18-000002
Insider Transaction Report
Form 4
GLADNEY DAN W
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2018-04-18+4,164,281→ 4,164,281 totalExercise: $0.65Exp: 2028-04-18→ Common stock (4,164,281 underlying)
Holdings
- 1,925
Common Stock, $0.01 par value per share
Footnotes (1)
- [F1]Subject to the employee's continued service, 25% of shares will vest on the one-year anniversary of April 18, 2018 and the remaining 75% of shares will vest in as nearly equal amounts as possible on the last day of the next 36 months thereafter.
Documents
Issuer
ReShape Lifesciences Inc.
CIK 0001371217
Entity typeother
Related Parties
1- filerCIK 0001224184
Filing Metadata
- Form type
- 4
- Filed
- Apr 19, 8:00 PM ET
- Accepted
- Apr 20, 4:54 PM ET
- Size
- 6.0 KB